{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:15:56Z","timestamp":1791234956715,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T00:00:00Z","timestamp":1481673600000},"content-version":"vor","delay-in-days":379,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ccell.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T18:31:03Z","timestamp":1447957863000},"page":"758-772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Constitutive Activation of mTORC1 in Endothelial Cells Leads to the Development and Progression of Lymphangiosarcoma through VEGF Autocrine Signaling"],"prefix":"10.1016","volume":"28","author":[{"given":"Shaogang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haige","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid L.","family":"Bergin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Lin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2015.10.004_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","author":"Agulnik","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2015.10.004_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2230.1999.00476.x","article-title":"Chronic lymphoedema and angiosarcoma","volume":"24","author":"Azurdia","year":"1999","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ccell.2015.10.004_bib3","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1101\/gad.1024602","article-title":"c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression","volume":"16","author":"Baudino","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2015.10.004_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10456-009-9148-2","article-title":"Vasculogenesis in infantile hemangioma","volume":"12","author":"Boscolo","year":"2009","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ccell.2015.10.004_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfp131","article-title":"Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance","volume":"111","author":"Cohen","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ccell.2015.10.004_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2015.10.004_bib7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/labinvest.2013.98","article-title":"Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin","volume":"93","author":"Du","year":"2013","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ccell.2015.10.004_bib8","first-page":"5173","article-title":"Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin","volume":"63","author":"El-Hashemite","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2015.10.004_bib9","first-page":"375","article-title":"Vascular tumors and vascular malformations (new issues)","volume":"13","author":"Enjolras","year":"1997","journal-title":"Adv. Dermatol."},{"key":"10.1016\/j.ccell.2015.10.004_bib10","series-title":"Color Atlas of Vascular Tumors and Vascular Malformations","author":"Enjolras","year":"2007"},{"key":"10.1016\/j.ccell.2015.10.004_bib11","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1074\/jbc.R109.094003","article-title":"Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony","volume":"285","author":"Foster","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2015.10.004_bib12","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1182\/blood-2003-11-3952","article-title":"Genetically tagging endothelial cells in\u00a0vivo: bone marrow-derived cells do not contribute to tumor endothelium","volume":"104","author":"G\u00f6thert","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2015.10.004_bib13","doi-asserted-by":"crossref","first-page":"a006460","DOI":"10.1101\/cshperspect.a006460","article-title":"Infantile hemangioma-mechanism(s) of drug action on a vascular tumor","volume":"1","author":"Greenberger","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ccell.2015.10.004_bib14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ccell.2015.10.004_bib15","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2015.10.004_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/bjc.1984.66","article-title":"Endothelial proliferation in tumours and normal tissues: continuous labelling studies","volume":"49","author":"Hobson","year":"1984","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2015.10.004_bib17","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1158\/1078-0432.CCR-08-0652","article-title":"Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3","volume":"14","author":"Hu-Lowe","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2015.10.004_bib18","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1-TSC2 complex is required for proper activation of mTOR complex 2","volume":"28","author":"Huang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ccell.2015.10.004_bib19","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/pbc.25067","article-title":"Malignant transformation of infantile hemangioma to angiosarcoma: response to chemotherapy with bevacizumab","volume":"61","author":"Jeng","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ccell.2015.10.004_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/75997","article-title":"Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema","volume":"25","author":"Karkkainen","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2015.10.004_bib21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4161\/cbt.2.5.446","article-title":"Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis","volume":"2","author":"Kwiatkowski","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ccell.2015.10.004_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","article-title":"A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells","volume":"11","author":"Kwiatkowski","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccell.2015.10.004_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s00431-015-2572-y","article-title":"Sirolimus for the treatment of children with various complicated vascular anomalies","author":"Lackner","year":"2015","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ccell.2015.10.004_bib24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1158\/1541-7786.MCR-14-0178","article-title":"A vascular model of Tsc1 deficiency accelerates renal tumor formation with accompanying hemangiosarcomas","volume":"13","author":"Leech","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ccell.2015.10.004_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","article-title":"VEGFs and receptors involved in angiogenesis versus lymphangiogenesis","volume":"21","author":"Lohela","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ccell.2015.10.004_bib26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2353\/ajpath.2006.050834","article-title":"Vascular endothelial growth factor localization in the adult","volume":"168","author":"Maharaj","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2015.10.004_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2559.2010.03484.x","article-title":"Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas","volume":"56","author":"Mankey","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.ccell.2015.10.004_bib28","doi-asserted-by":"crossref","first-page":"e42913","DOI":"10.1371\/journal.pone.0042913","article-title":"Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF","volume":"7","author":"Medici","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ccell.2015.10.004_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/PAS.0b013e318236c312","article-title":"Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors","volume":"36","author":"Miettinen","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccell.2015.10.004_bib30","first-page":"2641","article-title":"The Kaposi\u2019s sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt\/protein kinase B","volume":"61","author":"Montaner","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2015.10.004_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1535-6108(02)00237-4","article-title":"Endothelial infection with KSHV genes in\u00a0vivo reveals that vGPCR initiates Kaposi\u2019s sarcomagenesis and can promote the tumorigenic potential of viral latent genes","volume":"3","author":"Montaner","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2015.10.004_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2015.10.004_bib33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archdermatol.2011.2819","article-title":"Angiosarcoma of the scalp successfully treated with a single therapy of sorafenib","volume":"148","author":"Ono","year":"2012","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ccell.2015.10.004_bib34","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/cncr.11667","article-title":"Cutaneous angiosarcoma of the scalp: a multidisciplinary approach","volume":"98","author":"Pawlik","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ccell.2015.10.004_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ccr.2006.07.003","article-title":"Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin","volume":"10","author":"Phung","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2015.10.004_bib36","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/nprot.2010.113","article-title":"Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice","volume":"5","author":"Pitulescu","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2015.10.004_bib37","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1200\/JCO.2012.42.4531","article-title":"Lymphangiosarcoma of the thorax and thoracic vertebrae in a 16-year-old girl","volume":"30","author":"Quarmyne","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2015.10.004_bib38","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1200\/JCO.2012.41.7287","article-title":"Efficacy of rapamycin for refractory hemangioendotheliomas in Maffucci\u2019s syndrome","volume":"30","author":"Riou","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2015.10.004_bib39","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00000478-200210000-00009","article-title":"Angiosarcoma arising in hemangioma\/vascular malformation: report of four cases and review of the literature","volume":"26","author":"Rossi","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccell.2015.10.004_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/lrb.2007.1012","article-title":"Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in\u00a0vivo","volume":"5","author":"Shirazi","year":"2007","journal-title":"Lymphat. Res. Biol."},{"key":"10.1016\/j.ccell.2015.10.004_bib41","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1073\/pnas.0400835101","article-title":"Akt plays a central role in sarcomagenesis induced by Kaposi\u2019s sarcoma herpesvirus-encoded G protein-coupled receptor","volume":"101","author":"Sodhi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2015.10.004_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ccr.2006.05.026","article-title":"The TSC2\/mTOR pathway drives endothelial cell transformation induced by the Kaposi\u2019s sarcoma-associated herpesvirus G protein-coupled receptor","volume":"10","author":"Sodhi","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2015.10.004_bib43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u2019s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2015.10.004_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2004.09.026","article-title":"Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis","volume":"6","author":"Tang","year":"2004","journal-title":"Cancer Cell"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610815003815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610815003815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T15:53:22Z","timestamp":1537199602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610815003815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1535610815003815"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2015.10.004","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Constitutive Activation of mTORC1 in Endothelial Cells Leads to the Development and Progression of Lymphangiosarcoma through VEGF Autocrine Signaling","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}